Delivery Order SPE2DB20D3303-SPE2DB24FA0YF

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,549.76, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of March 7, 2025. The contract covers the procurement of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant...
This federal contract award, valued at $40,970.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a performance period ending on June 25, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $2,812.95, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through December 15, 2023. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is a delivery order valued at $31,670.10 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a period of performance through June 13, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,067.49, is a delivery order for the product "JARDIANCE 25 MG TABLET 90S" with a completion date of December 18, 2023. The contract is a firm fixed-price type with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $10,538.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a performance period ending on November 13, 2024. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $53,237.59 firm fixed price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $28,273.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a medication used in the treatment of diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $99,958.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and Firm Fixed Price type, with an ultimate completion date of March 7, 2025. The award covers the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,163.57 firm fixed-price delivery order is for JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a completion date of August 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0YF
    Delivery Order

This federal contract award, valued at $18,051.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of July 15, 2024, for the provision of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product.

The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/17/25, 9:59 AM